Dr. Giannakis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Avenue
Boston, MA 02115Phone+1 617-582-7263
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2011 - 2014
- Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2011
- Washington University in St. Louis School of MedicineClass of 2009
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- CA State Medical License 2016 - Present
- MA State Medical License 2011 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer Start of enrollment: 2020 Apr 16
Roles: Principal Investigator, Contact
- Dabrafenib + Trametinib + PDR001 In Colorectal Cancer Start of enrollment: 2018 Oct 15
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Waist circumference, a body shape index, and molecular subtypes of colorectal cancer: A pooled analysis of four cohort studies.Christos V Chalitsios, Georgios Markozannes, Christos Papagiannopoulos, Elom K Aglago, Sonja I Berndt
Cancer Epidemiology, Biomarkers & Prevention. 2025-02-03 - Rethinking the rise of early onset gastrointestinal cancers: a call to action.Benjamin A Weinberg, Caitlin C Murphy, David R Freyer, K Leigh Greathouse, Jan K Blancato
JNCI Cancer Spectrum. 2025-01-15 - A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer.Brandon M Huffman, Osama E Rahma, Kevin Tyan, Yvonne Y Li, Anita Giobbie-Hurder
Cancer Immunology Research. 2025-01-09
Authored Content
- Vitamin D Status After Colorectal Cancer Diagnosis and Patient Survival According to Immune Response to TumourOctober 2018
Press Mentions
- The Mystery of What’s Causing Young People’s Cancer Leads to the GutJanuary 3rd, 2025
- Experts Suggest Main Reasons Why Certain Cancer Type Is Rising in Young People WorldwideDecember 14th, 2024
- Scientists Continue Debate on Finding Causes for Colon CancerMarch 27th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: